This November, more than 8,000 life sciences leaders, investors, innovators and dealmakers will gather in Cologne, Germany, for BIO-Europe, Europe’s premier partnering event. With an expanded programme spanning seven specialist content tracks alongside world-class partnering opportunities, BIO-Europe 2026 promises to be one of the most strategically valuable meetings of the industry’s calendar.
To non-German speakers the city’s name, written in English, looks like it could be something to do with perfume. And that’s because it is. If you’ve ever splashed a bit of fragrant ‘Eau de Cologne’ about, you might have thought you were being very French, but in fact that perfume main-stay was invented in Cologne by an Italian perfumer, Johann Maria Farina, way back in 1709. In German, the city’s name is Köln, so there is no linguistic association with perfume.
Cologne’s long history of chemical engineering makes it a fitting host for Europe’s largest partnering event. Cologne is in North Rhine-Westphalia, which is an international hub for industry, research, and innovation. Accounting for around a quarter of all foreign direct investment into Germany, it’s one of the world’s, not just Europe’s, most important economic centres. Within the region is the BIO-NRW cluster, with over 500 life sciences companies, which you can check out on this handy database.
What’s special about this year’s BIO-Europe event? Like an expert parfumier crafting a new fragrance range for the very first time, the ’26 program will have six specialized content tracks. Where previously the program was mainly built around partnering & deal making, now there are intriguing other scented avenues to explore. These include therapeutic insights, ecosystem innovation, regulatory, clinical and biomanufacturing strategies. The last has become particularly important especially for more complex biologics, as, just like with perfumes, if you can’t make it reproducibly and efficiently at scale, you can’t make a viable business.
In the therapeutic insights track, you can explore where science meets strategy. This track spotlights the most exciting areas of innovation – the headiest fragrances and the ‘heart notes’ of the program – from neuroscience and rare diseases to women’s health and longevity. Check out sessions which explore what the data shows for ADCs in oncology, what matters next for radioligand therapy, and precisely where we’re at with cardiometabolic innovation beyond GLP-1.
As society’s nasal ‘taste’ for aromas has evolved this millennium from woodier scents (think sandalwood) to sweeter scents (think citrus fruits) making perfume has become more difficult, and art has become science. Some compounds are just too difficult, or expensive, to extract naturally or are too volatile. For example, ambergris, produced in the digestive tracts of sperm whales to protect their guts from their daily diet of squids with sharp beaks, has long been prized in the fragrance industry for its property of making perfumes last longer, and adding a certain ‘Eau de Cetacea’ marine aroma. However, fragrances derived from endangered species are undesirable. So unique synthetic notes, created artificially, are now commonplace. Where the parfumiers have ventured, the chemists have followed, and in life sciences, cell and gene therapies are making great advances, and are about as far-removed from ‘simple’ small molecules as an incense stick is to an iconic torso-shaped perfume bottle from Jean Paul Gaultier.
Part of the Big Picture plenary series will debate, ‘Women’s health: the greatest market failure and commercial opportunity in modern biopharma’. How much value has the industry left untapped by historically under-investing in women’s health and failing to represent sex-based differences in research and development? Everyone knows colognes have been developed for men and women – the invigorating and refreshing fragrance icon 4711 Original Eau de Cologne, with its secret recipe of ‘aqua mirabilis’, is one of the oldest brands in the world… so can we strive for the same emphasis on inclusivity in life sciences?
While the expanded programme brings fresh opportunities for learning and discussion, partnering remains at the heart of BIO-Europe. With thousands of one-on-one meetings scheduled throughout the week, many of the industry’s most important licensing, investment and strategic partnering discussions begin here. Whether you are seeking investors, licensing opportunities, strategic collaborations or acquisition targets, the event remains one of the most efficient ways to connect with decision makers from across the global life sciences ecosystem.
Register early to secure the best rates and start planning your partnering schedule. BIO-Europe 2026 could be where your next licensing deal, strategic collaboration, investment or breakthrough opportunity begins.
Top tourist tip:
If you’re fascinated by the magic of fragrance, make a quick ‘make-over’ stop at the historic Farina Fragrance museum. This is the world’s oldest perfume house, where you can create your very own ‘Eau de Cologne’. Also treat your nose and eyes to a visit to the 4711 Fragrance House with its fascinating architecture and join a fragrance seminar. What could smell sweeter that your own personalised perfume?